Biosimilars Group Pushes For Medicine Access Measures
A biosimilars and generic-drug industry trade group has urged federal lawmakers to set their sights on measures to ensure that patients can more easily get their hands on biosimilars, rein in...To view the full article, register now.
Already a subscriber? Click here to view full article